486 related articles for article (PubMed ID: 26776393)
1. [Negative symptoms of schizophrenia: from electrophysiology to electrotherapy].
Micoulaud Franchi JA; Quiles C; Belzeaux R; Adida M; Azorin JM
Encephale; 2015 Dec; 41(6 Suppl 1):6S50-6. PubMed ID: 26776393
[TBL] [Abstract][Full Text] [Related]
2. [Interactive rTMS protocols in psychiatry].
Micoulaud-Franchi JA; Richieri R; Lancon C; Vion-Dury J
Encephale; 2013 Dec; 39(6):426-31. PubMed ID: 23810752
[TBL] [Abstract][Full Text] [Related]
3. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial.
Wobrock T; Guse B; Cordes J; Wölwer W; Winterer G; Gaebel W; Langguth B; Landgrebe M; Eichhammer P; Frank E; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Malchow B; Schneider-Axmann T; Falkai P; Hasan A
Biol Psychiatry; 2015 Jun; 77(11):979-88. PubMed ID: 25582269
[TBL] [Abstract][Full Text] [Related]
4. Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: Meta-analysis of controlled trials.
Aleman A; Enriquez-Geppert S; Knegtering H; Dlabac-de Lange JJ
Neurosci Biobehav Rev; 2018 Jun; 89():111-118. PubMed ID: 29471017
[TBL] [Abstract][Full Text] [Related]
5. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis.
Dlabac-de Lange JJ; Knegtering R; Aleman A
J Clin Psychiatry; 2010 Apr; 71(4):411-8. PubMed ID: 20361909
[TBL] [Abstract][Full Text] [Related]
6. [Noninvasive cerebral stimulation for treatment of ADHD: A review of the literature].
Brandejsky L; Micoulaud Franchi JA; Lopez R; Bioulac S; Da Fonseca D; Daudet C; Boyer L; Richieri R; Lançon C
Encephale; 2017 Oct; 43(5):457-463. PubMed ID: 27745724
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia.
Arumugham SS; Thirthalli J; Andrade C
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1245-52. PubMed ID: 27322602
[TBL] [Abstract][Full Text] [Related]
8. Can repetitive transcranial magnetic stimulation be considered effective treatment option for negative symptoms of schizophrenia?
Prikryl R; Kucerova HP
J ECT; 2013 Mar; 29(1):67-74. PubMed ID: 23303418
[TBL] [Abstract][Full Text] [Related]
9. Treatment of shizophrenic patients and rTMS.
Poulet E; Haesebaert F; Saoud M; Suaud-Chagny MF; Brunelin J
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S143-6. PubMed ID: 21057425
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of non-invasive brain stimulation on the symptom dimensions of schizophrenia: A meta-analysis of randomized controlled trials.
Kennedy NI; Lee WH; Frangou S
Eur Psychiatry; 2018 Mar; 49():69-77. PubMed ID: 29413808
[TBL] [Abstract][Full Text] [Related]
11. Resting State Dense Array Gamma Oscillatory Activity as a Response Marker for Cerebellar-Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia.
Tikka SK; Garg S; Sinha VK; Nizamie SH; Goyal N
J ECT; 2015 Dec; 31(4):258-62. PubMed ID: 25923998
[TBL] [Abstract][Full Text] [Related]
12. Effect of rTMS on brain activation in schizophrenia with negative symptoms: A proof-of-principle study.
Dlabac-de Lange JJ; Liemburg EJ; Bais L; Renken RJ; Knegtering H; Aleman A
Schizophr Res; 2015 Oct; 168(1-2):475-82. PubMed ID: 26187147
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
Hansbauer M; Wobrock T; Kunze B; Langguth B; Landgrebe M; Eichhammer P; Frank E; Cordes J; Wölwer W; Winterer G; Gaebel W; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Malchow B; Strube W; Schneider-Axmann T; Falkai P; Hasan A
Psychiatry Res; 2018 May; 263():22-29. PubMed ID: 29482042
[TBL] [Abstract][Full Text] [Related]
14. [Non-invasive brain stimulation for treatment of schizophrenic psychoses].
Hasan A; Wobrock T; Palm U; Strube W; Padberg F; Falkai P; Fallgatter A; Plewnia C
Nervenarzt; 2015 Dec; 86(12):1481-91. PubMed ID: 26341690
[TBL] [Abstract][Full Text] [Related]
15. High frequency repetitive transcranial magnetic stimulation (rTMS) reduces EEG-hypofrontality in patients with schizophrenia.
Kamp D; Brinkmeyer J; Agelink MW; Habakuck M; Mobascher A; Wölwer W; Cordes J
Psychiatry Res; 2016 Feb; 236():199-201. PubMed ID: 26778629
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.
Jin Y; Potkin SG; Kemp AS; Huerta ST; Alva G; Thai TM; Carreon D; Bunney WE
Schizophr Bull; 2006 Jul; 32(3):556-61. PubMed ID: 16254067
[TBL] [Abstract][Full Text] [Related]
17. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study.
Mogg A; Purvis R; Eranti S; Contell F; Taylor JP; Nicholson T; Brown RG; McLoughlin DM
Schizophr Res; 2007 Jul; 93(1-3):221-8. PubMed ID: 17478080
[TBL] [Abstract][Full Text] [Related]
18. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study.
Prikryl R; Kasparek T; Skotakova S; Ustohal L; Kucerova H; Ceskova E
Schizophr Res; 2007 Sep; 95(1-3):151-7. PubMed ID: 17689931
[TBL] [Abstract][Full Text] [Related]
19. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.
Slotema CW; Blom JD; Hoek HW; Sommer IE
J Clin Psychiatry; 2010 Jul; 71(7):873-84. PubMed ID: 20361902
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis.
Osoegawa C; Gomes JS; Grigolon RB; Brietzke E; Gadelha A; Lacerda ALT; Dias ÁM; Cordeiro Q; Laranjeira R; de Jesus D; Daskalakis ZJ; Brunelin J; Cordes J; Trevizol AP
Schizophr Res; 2018 Jul; 197():34-44. PubMed ID: 29397282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
